(Press-News.org) Sophia Antipolis, 6 September 2012: The European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a registered branch of the European Society of Cardiology (ESC), and the American Heart Association (AHA) have today issued a joint scientific statement http://eurheartj.oxfordjournals.org/content/early/2012/08/24/eurheartj.ehs221.short?rss=1 that sets out to produce easy-to-follow guidance on Clinical Cardiopulmonary Exercise (CPX) testing based on current scientific evidence. The document, which has been published simultaneously online in the European Heart Journal and Circulation, is intended to stimulate greater uptake of clinically warranted CPX assessments and potentially open the way for the initiation of multi-centre international trials utilising the technology.
"The ultimate goal of the statement is to both increase awareness of the value of CPX and the number of healthcare professionals feeling able to undertake clinically meaningful CPX interpretations. For each indication we've paired the information down to an easily digestible one page report," says Marco Guazzi, M.D., The European co-chair of the writing group.
The statement, which is viewed as a major step-forward, represents the first joint statement produced by the EACPR and AHA. "The purpose of producing joint recommendations is to deliver an internationally consistent statement that will prevent confusion with respect to the most relevant information gained from a CPX for a given patient. Providing universal reporting recommendations may also facilitate international multicentre trials using CPX as a study endpoint when appropriate," explains Ross Arena, M.D., the American co-chair of the writing group.
CPX, which is recognised as the gold standard aerobic exercise testing assessment, merges traditional exercise testing procedures (ECG, blood pressure, perceived exertion etcetera) with analysis of ventilatory expired gases including information such as oxygen consumption, carbon dioxide production and minute ventilation (the volume of gas produced over the time period of a minute).
"CPX provides a much better idea of the underlying pathophysiology than routine exercise testing and allows better targeting of treatments," says Guazzi, a cardiologist from the University of Milano, Italy.
CPX also gives an indication of what is occurring at the cellular level in the muscles. "It can provide both valuable diagnostic information and also prognostic information about the likely outcome for individual patients," says Arena, a professor at the University of New Mexico Health Sciences Centre in Albuquerque, New Mexico, U.S.A. Taking the example of heart failure, he says, information derived from CPX testing can be used to gauge the urgency of transplantation.
While clinical use of CPX is firmly established in patients with systolic heart failure and unexplained exertional dyspnoea, emerging evidence now strongly suggests CPX has "clinical utility" in patients with suspected/ confirmed pulmonary arterial hypertension or secondary pulmonary hypertension, pulmonary disease, hypertrophic cardiomyopathy, suspected myocardial ischemia, and suspected mitochondrial myopathy.
But undermining the use of the technology have been the difficulties experienced by health care professionals in the interpretation of the data. This, says Arena, has been caused by the fact that many current CPX software packages generate "an overwhelming abundance of data" that is difficult to decipher. "While some centres have appropriately trained health professionals who can interpret the data and produce succinct reports, in many places interpretation is left to the health care professional who orders the test. If they haven't been trained interpretation can be a daunting task," says Arena.
The EACPR and AHA have gained the "distinct impression" that the confusion around interpretation is leading to suboptimal utilisation of this valuable technology. "We strongly feel that if the tests were easier to interpret this would lead to increased utilization of the technology," says Guazzi.
The joint statement sets out to empower clinicians to take control and undertake their own interpretations. First, the document reviews the body of original research in CPX and justifies which variables should be assessed for each given indication. Next a colour coded one page reporting sheet has been devised for each indication, giving a range of readings graded green, yellow, orange or red. Responses in the green zone indicate a normal response for a given variable, while responses in the yellow, orange and red zones indicate progressively greater abnormalities.
In addition to heart failure and unexplained exertional dyspnoea, tables are provided for suspected or confirmed hypertrophic cardiomyopathy, suspected or confirmed pulmonary arterial hypertension/ secondary pulmonary hypertension, chronic obstructive lung disease or interstitial lung disease, suspected myocardial ischemia and suspected mitochondrial myopathy.
The authors have also devised a "universal CPX reporting form" that outlines the information that needs to be collected according to the specific conditions. "In the past labs haven't performed or recorded the tests in the same way. For example some use peak un-averaged values of oxygen consumption, while others use average values, and others the last 30 second average values. Getting all centres to report the information in the same way opens the way for multicentre trials using CPX data in a consistent way," explains Guazzi.
One such study that could be undertaken would be a large scale prospective studies for each condition that links patients' CPX scores to their outcomes.
"Looking to the future I really hope that the companies who produce the computer soft ware programmes analysing the reading will embrace our recommendations and use it to produce information that's even easier for clinicians to interpret," says Arena.
###
Notes to editor
About the Writing Committee
EACPR Writing Committee: Marco Guazzi (co-chair), Volker Adams, Viviane Conraads, Martin Halle, Alessandro Mezzani and Luc Vanhees.
AHA Writing Committee: Ross Arena (co-chair), Gerald Fletcher, Daniel Forman, Dalane Kitzman, Carl Lavie and Jonathan Myers.
About the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
The European Association for Cardiovascular Prevention & Rehabilitation (EACPR) is a registered branch of the ESC. Its aim is to promote excellence in research, practice, education and policy in cardiovascular prevention and rehabilitation in Europe.
http://www.escardio.org/communities/EACPR/Pages/welcome.aspx
About the European Society of Cardiology
The European Society of Cardiology (ESC) represents more than 75,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
http://www.escardio.org/
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – America's No. 1 and No. 4 killers. We team with millions of volunteers to fund innovative research, fight for stronger public health policies, and provide lifesaving tools and information to prevent and treat these diseases. http://www.heart.org/
References
Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. European Heart Journal. Doi: 10.1093/eurheartj/ehs221
Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012: published online before print September 5, 2012, 10.1161/CIR.0b013e31826fb946.
Joint EACPR and AHA statement empowers health care professional to use Clinical Cardiopulmonary Exercise Testing
2012-09-06
ELSE PRESS RELEASES FROM THIS DATE:
Family literacy project exceeds expectations
2012-09-06
A unique approach to early literacy work with families where children develop their language skills and their ability to read and write from an early age has had a huge success.
Researchers from the University of Sheffield funded by the Economic and Social Research Council (ESRC) initially planned to use the approach with around 60 families, but discovered that around 6,000 had actually benefited from their work.
Professor Cathy Nutbrown of the University of Sheffield, who led the project, shared her approach to family literacy with Early Years practitioners including ...
Advanced maternal age not harmful for adult children
2012-09-06
This press release is available in German.
It had been thought that mothers delivering later in life have children that are less healthy as adults, because the body of the mother had already degenerated due to physiological effects like decreasing oocyte quality or a weakened placenta. In fact, what affects the health of the grown-up children is not the age of their mother but her education and the number of years she survives after giving birth and thus spends with her offspring. This is the conclusion of a new study by Mikko Myrskylä from the Max Planck Institute for ...
Multi-functional anti-inflammatory/anti-allergic developed by Hebrew University researcher
2012-09-06
Jerusalem, Sept. 6, 2012 – A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.
The researcher is Saul Yedgar, who is the Walter and Greta Stiel Professor of Heart Studies at the Institute for Medical Research Israel-Canada at the Hebrew University Faculty of Medicine.
Inflammatory/allergic diseases affect billions of people worldwide, and treatments for these conditions are a major focus of the pharmaceutical industry. ...
Earlier treatment for young patients with chronic hepatitis B more effective in clearing virus
2012-09-06
Scientists from A*STAR's Singapore Institute for Clinical Sciences (SICS), together with clinical collaborators from London , discovered for the first time that children and young patients with chronic Hepatitis B Virus infection (HBV carriers) do have a protective immune response, contrary to current belief, and hence can be more suitable treatment candidates than previously considered.
This discovery by the team of scientists led by Professor Antonio Bertoletti, programme director and research director of the infection and immunity programme at SICS, could lead to ...
Mars's dramatic climate variations are driven by the Sun
2012-09-06
On Mars's poles there are ice caps of ice and dust with layers that reflect to past climate variations on Mars. Researchers from the Niels Bohr Institute have related the layers in the ice cap on Mars's north pole to variations in solar insolation on Mars, thus established the first dated climate history for Mars, where ice and dust accumulation has been driven by variations in insolation. The results are published in the scientific journal, Icarus.
The ice caps on Mars's poles are kilometres thick and composed of ice and dust. There are layers in the ice caps, which ...
A brain filter for clear information transmission
2012-09-06
This press release is available in German. Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
How does this refined control system work? How can inhibitory signals produce precise output signals? This was the question investigated by Remy and his colleagues. Scientists have known ...
Human genome far more active than thought
2012-09-06
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
Among their discoveries, the team describe more than 10,000 novel genes, identify genes that have 'died' and others that are being resurrected. The GENCODE Consortium reference gene catalogue has been one of the underpinnings of the larger ...
Survival 'excellent' following living donor liver transplantation for acute liver failure
2012-09-06
Patients in Japan who underwent living donor liver transplantation (LDLT) for acute liver failure (ALF) were classified as having excellent outcomes, with ten-year survival at 73%. The findings, published in the September issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases (AASLD), suggest that the type of liver disease or treatment plan does not affect long-term patient survival following LDLT. Donor and patient age, however, does impact long-term outcome post-transplant.
According to the AASLD, roughly 2,000 Americans ...
Destroyed coastal habitats produce significant greenhouse gas
2012-09-06
DURHAM, N.C. -- Destruction of coastal habitats may release as much as 1 billion tons of carbon emissions into the atmosphere each year, 10 times higher than previously reported, according to a new Duke led study.
Published online this week in PLOS ONE, the analysis provides the most comprehensive estimate of global carbon emissions from the loss of these coastal habitats to date: 0.15 to 1.2 billion tons. It suggests there is a high value associated with keeping these coastal-marine ecosystems intact as the release of their stored carbon costs roughly $6-$42 billion ...
Storm of 'awakened' transposons may cause brain-cell pathologies in ALS, other illnesses
2012-09-06
Cold Spring Harbor, NY – A team of neuroscientists and informatics experts at Cold Spring Harbor Laboratory (CSHL) reports important progress in an effort to understand the relationship between transposons – sequences of DNA that can jump around within the genome, potentially causing great damage – and mechanisms involved in serious neurodegenerative disorders including ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig's disease), FTLD (frontotemporal lobar degeneration) and Alzheimer's disease.
A close analysis of previously unanalyzed genome data has led ...